Accepted answer
The relevant point is that whoever receives the consignment is the importer, with whatever that means in their jurisdiction.
The real saving is in carriage and in unit price breaks, not in the compound itself. Carriage on a single larger consignment is typically a fraction of the sum of individual shipments, and that is where most of the arithmetic comes from.
Cost per milligram, adjusted honestly
| Step | Value | Note |
|---|
| Vial price, 10 mg nominal | £34.00 | As advertised |
| Nominal cost per mg | £3.40 | 34 ÷ 10 |
| Measured content | 9.2 mg | Independent content assay |
| Cost per actual mg | £3.70 | 34 ÷ 9.2 |
| Dead-space loss, 20 draws | 4 % | 80 µL of a 2 mL fill |
| Cost per delivered mg | £3.85 | 3.70 ÷ 0.96 |
| First vial, with £110 assay | £14.85 | Testing dominates a single vial |
More usefully, whoever receives the consignment is the importer of record in most jurisdictions, regardless of who paid. That is a legal position rather than an administrative one and it does not divide among contributors.
Carriage costs on international consignments scale far less than linearly with weight, which is the arithmetic basis for the saving.
The caveat is legal rather than analytical: onward supply is treated differently from personal importation in many jurisdictions and the difference is not a technicality.
Whoever receives it is the importer. Make sure that person knows.
edited 18 Dec 2025 by w_okoye — tightened the wording; no substantive change